The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity
Open accessAbstract
The induction of a calcium‐independent isoform of nitric oxide (NO) synthase (iNOS) and a subsequent enhanced formation of NO has been implicated in the pathophysiology of a variety of diseases including inflammation and circulatory shock. Here we demonstrate that the S‐substituted isothioureas, S‐methylisothiourea (SMT), S‐(2‐aminoethyl)isothiourea (aminoethyl‐TU), S‐ethylisothiourea (ethyl‐TU) and S‐isopropylisothiourea (isopropyl‐TU) potently inhibit iNOS activity in J774.2 macrophages activated with bacterial endotoxin with EC 50 values 8–24 times lower than that of N G‐methyl‐l‐arginine (MeArg) and 200‐times lower than that of N G‐nitro‐l‐arginine (l‐NO 2 Arg). The inhibition of iNOS activity by these S‐substituted isothioureas is dose‐dependently prevented by excess of l‐arginine suggesting that these isothioureas are competitive inhibitors of iNOS at the l‐arginine binding site. Ethyl‐TU and isopropyl‐TU are 4–6 times more potent than MeArg in inhibiting the constitutive NOS activity in homogenates of bovine aortic endothelial cells (eNOS) and are more potent pressor agents than MeArg in the anaesthetized rat. SMT is equipotent with MeArg, whereas aminoethyl‐TU is 6‐times less potent in inhibiting eNOS activity in vitro. Both SMT and aminoethyl‐TU, however, elicit only weak pressor responses (approximately 15mmHg at 10 mg kg−1, i.v.)in vivo. A comparison of the potencies of ethyl‐, iso‐propyl‐, n‐propyl‐, t‐butyl‐ and n‐butyl‐isothioureas on iNOS activity shows that the inhibitory activity of S‐substituted isothioureas declines sharply if the side chain exceeds 2 carbon atoms in length. Similarly, substitution of the ethylene side chain of ethyl‐TU also results in a diminished potency. Substitution of either one or both nitrogens of SMT with either amino or alkyl groups also substantially reduces its NOS inhibitory potency. In conclusion, isothioureas represent a new class of NOS inhibitors which includes the most potent inhibitors of iNOS activity reported to date. Some members of this class (ethyl‐TU and isopropyl‐TU) are potent inhibitors of eNOS and iNOS with little selectivity towards either isoform, while others (SMT and aminoethyl‐TU) are relatively selective inhibitors of iNOS activity. These latter agents may become useful tools for studying the role of iNOS in various disease models and may be useful in the therapy of diseases that are associated with an enhanced formation of NO due to iNOS induction, such as inflammation, circulatory shock or cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Nitric oxide as a secretory product of mammalian cells
Nathan, C. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.12.1381691 · Cited by 4,350
Bucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.
Vane, J. R., Mitchell, J. A., Appleton, I., Tomlinson, A., Bishop-Bailey, D., Croxtall, J., & Willoughby, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2046 · Cited by 1,033
Nitric Oxide: A Physiologic Messenger
Lowenstein, C. J., Dinerman, J. L., & Snyder, S. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00009 · Cited by 907
Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
Misko, T. P., Moore, W. M., Kasten, T. P., Nickols, G. A., Corbett, J. A., Tilton, R. G., McDaniel, M. L., Williamson, J. R., & Currie, M. G. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90357-n · Cited by 721
Suppression of arthritis by an inhibitor of nitric oxide synthase.
McCartney-Francis, N., Allen, J. B., Mizel, D. E., Albina, J. E., Xie, Q. W., Nathan, C. F., & Wahl, S. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.749 · Cited by 645
Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction
Corbett, J. A., Tilton, R. G., Chang, K., Hasan, K. S., Ido, Y., Wang, J. L., Sweetland, M. A., Lancaster, J. R., Williamson, J. R., & McDaniel, M. L. (1992) · Diabetes · doi:10.2337/diab.41.4.552 · Cited by 628
Thiemermann, C., & Vane, J. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90062-b · Cited by 528
Self-citationOrganic chemistry of bivalent sulfur
Reid, E. E. (1958) · Medical Entomology and Zoology · Cited by 492
Cited by
Inducible nitric oxide synthase: Regulation, structure, and inhibition
Cinelli, M. A., Do, H. T., Miley, G. P., & Silverman, R. B. (2020) · Medicinal Research Reviews · doi:10.1002/med.21599 · Cited by 889
Garvey, E. P., Oplinger, J. A., Furfine, E. S., Kiff, R. J., Laszlo, F., Whittle, B. J. R., & Knowles, R. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.4959 · Cited by 845
INHIBITION OF NITRIC OXIDE SYNTHASE AS A POTENTIAL THERAPEUTIC TARGET
Hobbs, A. J., Higgs, A., & Moncada, S. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.191 · Cited by 596
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms
Southan, G. J., & Szabó, C. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02099-3 · Cited by 569
Self-citationLPS induces apoptosis in macrophages mostly through the autocrine production of TNF-α
Xaus, J., Comalada, M., Valledor, A. F., Lloberas, J., López-Soriano, F., Argilés, J. M., Bogdan, C., & Celada, A. (2000) · Blood · doi:10.1182/blood.v95.12.3823 · Cited by 331
Metadata
- Authors
- Southan, G. J., Szabó, C., & Thiemermann, C.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1995-01
- Volume
- 114
- Issue
- 2
- Pages
- 510-516
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2024401413
- Cited by
- 278
- References
- 36
- FWCI
- 21.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. https://app.cochat.ai/papers/10.1111/j.1476-5381.1995.tb13256.x
- The paper
- Southan, G. J., Szabó, C., & Thiemermann, C. (1995). Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1995.tb13256.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.